RxDoctor Payments Data

Kathryn Quarls

Pediatrics · Covington, LANPI 1831125236

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 30.6% of the total. Reporting peaked in 2022 at $314 and has fallen 94.1% since, to $18 in 2023.

$605in general payments, 2019–2025

Across 33 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$185
  • GSK$126
  • Tris Pharma Inc$115
  • Merck$41
  • Corium, LLC$35
  • Ironshore Pharmaceuticals Inc.$24
  • plus $78 from 5 others
$352,010in research payments, 2019–2025

Across 53 payments — averaging $6641.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$352K

What the payments were for

  • Food & beverage$605100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$605 in reported general payments places this provider in the 65th percentile of 913 pediatrics providers in Louisiana.

See all pediatrics providers in Louisiana

Other pediatrics in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →